Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Northrop Grumman (NOC)

Northrop Grumman Q1 profit falls on $477 million B-21 charge; 2025 profit guidance cut

Negative Impact 4 of 5 earnings Written later

Northrop Grumman reported first-quarter 2025 sales of $9.5 billion, down 7 percent, and diluted EPS of $3.32 versus $6.32 a year earlier, after a $477 million pre-tax loss provision on the B-21 program. The company cut its 2025 segment operating income guidance to $4.2 billion-$4.35 billion from $4.65 billion-$4.8 billion and its MTM-adjusted EPS guidance to $24.95-$25.35 from $27.85-$28.25, while reaffirming its sales and free cash flow guidance. Lower profit expectations for 2025 are the key development for shareholders.

Key points

  • Q1 2025 sales were $9.5 billion, down from $10.1 billion in Q1 2024.
  • Diluted EPS was $3.32 versus $6.32, including a $2.74 per share impact from the B-21 loss provision.
  • 2025 MTM-adjusted EPS guidance was lowered to $24.95-$25.35 from $27.85-$28.25.
  • 2025 sales guidance of $42.0 billion-$42.5 billion and free cash flow guidance of $2.85 billion-$3.25 billion were reaffirmed.

The filing

CompanyNorthrop Grumman (NOC)
Form8-K, current report
Filed with the SECApr 22, 2025, 6:45 AM ET
Accession number0001133421-25-000022

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 1:21 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on April 22, 2025.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.